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Purpose: According to the Centers for Disease Control (CDC), one-third
of adults have prediabetes and are at risk for developing type 2
diabetes, a leading risk factor for cardiovascular disease. The Diabetes
Prevention Program (DPP) focuses on lifestyle modi cations to help
participants lose 5-7% of their body weight and prevent type 2 diabetes.
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Prevention Program (DPP) focuses on lifestyle modi cations to help
participants lose 5-7% of their body weight and prevent type 2 diabetes.
The purpose of this study is to determine whether successful
completion of the DPP is associated with a decrease in atherosclerotic
cardiovascular disease (ASCVD) risk.
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Methods: One-site, prospective cohort study. The DPP was
implemented on-site at Farmington Village Family Practice and virtually
via Zoom from January 2020 through December 2020. For the rst 6
months, participants met weekly for 1 hour. In the remaining 6 months,
sessions were held monthly for 1 hour. Each session began with a
private weigh-in followed by a uniquely designed lesson plan. Fourteen
patients who were prediabetic based on hemoglobin A1c(A1c), fasting
blood glucose, or diabetic risk score calculator. Systolic blood pressure
(SBP), diastolic blood pressure (DBP), smoking status, anti-hypertensive
medications, age, race, sex, hemoglobin A1c, fasting blood glucose, total
cholesterol and HDL were measured initially, at six months and at one
year. These parameters were used to calculate ASCVD risk percentages
based on the 2013 risk calculator from AHA/ACC.
Results: The 6-month analysis showed a statistically signi cant
improvement in ASCVD (mean initial 2.00, mean reduction 0.74, p <
0.001), SBP (mean initial SBP 129, mean reduction of 6.571 mmHg, p <
0.001), weight (mean initial weight 262 lbs, mean reduction of 24.643
lbs, p = 0.003), and HDL (mean initial HDL 40.86, mean increase of
7.143, p = 0.001). These data points will also be analyzed at the
completion of the study.
Conclusions: After 6 months of the DPP program, statistically signi cant
improvements in ASCVD, SBP, HDL and weight were observed. Once the
data is collected with regards to twelve-month vitals and lab values, a
similar statistical analysis will be performed. The ndings at the sixmonth mark are promising and are consistent with the reduction of
cardiovascular risk factors. These interim ndings further support the
value of a structured, evidence-based educational curriculum focused
on nonpharmacologic intervention for cardiovascular risk reduction.

Upon completion of this session, participants should be able to:
1. Identify the association of weight loss through a structured
program and reduction of type 2 diabetes and ASCVD risk.
2. Use the resources provided to implement the DPP for their clinic
patients.
3. Identify risk factors for type 2 diabetes and ASCVD.
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